Assessment of inflammatory markers as predictor of outcome in COVID-19 patients on noninvasive ventilator in ICU setup
Keywords:
COVID-19, laboratory parameters, C reactive, D dimer, ferritinAbstract
According to the existing evidence, inflammatory reactions appear to have a significant impact on the emergence of COVID-19. This study aims to determine the severity of COVID-19-associated laboratory measures, particularly in patients receiving non-invasive ventilation. METHOD: This observational study involved 150 patients who were on non-invasive ventilation and tested positive for the Covid19 RTPCR/GENEXPERT gene. C reactive protein, D dimer, and ferritin examinations were frequently collected and Data were entered. Microsoft Excel, and SPSS software version 17.0 was used for the statistical analysis. The components of descriptive statistics are mean, standard deviation, frequency, and percentage. Student T-test was used to evaluate CRP, D Dimer, and ferritin between covid positive patients' outcome variables P<0.05 significant analysis will be done using SPSS software version 25. Result: CRP levels were above 10; 131 patients with bad outcomes (59) and 73 patients (55.7) survived. Thirty-five patients (39%) and 55 patients (61%) with D-dimer values of 1 survived. 64 Patients (50.8%) with ferritin levels of more than 300 survived, while 62 Patients (48%) died. Conclusion: In our study population, elevated ferritin and D-dimer levels were found to be related to bad outcomes, whereas elevated CRP levels did not.
Downloads
References
Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet (London, England). 2020 Feb 15;395(10223):507–13.
Gopalan N, Senthil S, Prabakar NL, et al. Predictors of mortality among hospitalized COVID-19 patients and risk score formulation for prioritizing tertiary care-An experience from South India. PLoS One. 2022;17:e0263471.
Huang I, Lim MA, Pranata R. Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia - A systematic review, meta-analysis, and meta-regression. Diabetes Metab Syndr. 2020 Jul 1;14(4):395–403.
Huang I, Pranata R, Lim MA, Oehadian A, Alisjahbana B. C-reactive protein, procalcitonin, D-dimer, and ferritin in severe coronavirus disease-2019: a meta-analysis. Ther Adv Respir Dis. 2020;14:1753466620937175.
Huang I, Pranata R. Lymphopenia in severe coronavirus disease-2019 (COVID-19): Systematic review and meta-analysis. J Intensive Care. 2020 May 24;8(1).
Izcovich A, Ragusa MA, Tortosa F, et al. Prognostic factors for severity and mortality in patients infected with COVID-19: A systematic review. PLoS One. 2020;15:e0241955.
Koozi H, Lengquist M, Frigyesi A. C-reactive protein as a prognostic factor in intensive care admissions for sepsis: a Swedish multicenter study. J Crit Care. 2020;56:73–79.
Liu F, Li L, Xu M, et al. Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19. J Clin Virol. 2020;104370.
Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020 Mar 28;395(10229):1033–4.
Menzella F, Barbieri C, Fontana M, et al. Effectiveness of noninvasive ventilation in COVID-19 related-acute respiratory distress syndrome. Clin Respir J. 2021;15:779-787.
Poudel A, Poudel Y, Adhikari A, et al. D-dimer as a biomarker for assessment of COVID-19 prognosis: D-dimer levels on admission and its role in predicting disease outcome in hospitalized patients with COVID-19. PLoS ONE. 2021;16:e0256744.
Pranata R, Huang I, Lim MA, Wahjoepramono EJ, July J. Impact of cerebrovascular and cardiovascular diseases on mortality and severity of COVID-19-systematic review, meta-analysis, and meta-regression. J Stroke Cerebrovasc Dis. 2020 Aug 1;29(8):104949.
Pranata R, Huang I, Lukito AA, Raharjo SB. Elevated N-terminal pro-brain natriuretic peptide is associated with increased mortality in patients with COVID-19: systematic review and meta-analysis. Postgrad Med J. 2020 Jul 1;96(1137):387–91.
Ramos-Casals M, Brito-Zerón P, López-Guillermo A, et al. Adult haemophagocytic syndrome. Lancet. 2014;383:1503–1516.
Shah S, Shah K, Patel SB, Patel FS, Osman M, Velagapudi P, et al. Elevated D-dimer levels are associated with increased risk of mortality in coronavirus disease 2019: a systematic review and meta-analysis. Cardiol Rev. 2020;28:295-302..
Sharifpour M, Rangaraju S, Liu M, et al; Emory COVID-19 Quality & Clinical Research Collaborative. C-Reactive protein as a prognostic indicator in hospitalized patients with COVID-19. PLoS One. 2020 Nov 20;15(11):e0242400.
Sharma A, Ahmad Farouk I, Lal SK. COVID-19: A Review on the Novel Coronavirus Disease Evolution, Transmission, Detection, Control and Prevention. Viruses. 2021 Feb 1;13(2).
Shivalkar S, Pingali MS, Verma A, Singh A, Singh V, Paital B, et al. Outbreak of COVID-19: A Detailed Overview and Its Consequences. Adv Exp Med Biol. 2021;1353:23–45.
Song J, Park DW, Moon S, et al. Diagnostic and prognostic value of interleukin-6, pentraxin 3, and procalcitonin levels among sepsis and septic shock patients: a prospective controlled study according to the Sepsis-3 definitions. BMC Infect Dis. 2019;19:968.
Tang N., Li D., Wang X. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J. Thromb. Haemost. 2020;18:844–847.
Veronese N, Demurtas J, Yang L, et al. Use of corticosteroids in coronavirus disease 2019 pneumonia : a systematic review of the literature. Front Med. 2020;7:1–6.
World Health Organization. Coronavirus Disease (COVID-19) Situation Reports [Internet]. World Health Organization. 2022 [cited 2022 Aug 26]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
